BioCryst Pharmaceuticals
BCRX
BCRX
124 hedge funds and large institutions have $740M invested in BioCryst Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
21% less capital invested
Capital invested by funds: $938M → $740M (-$198M)
Holders
124
Holding in Top 10
3
Calls
$16.4M
Puts
$6.5M
Top Buyers
| 1 | +$28.9M | |
| 2 | +$13.7M | |
| 3 | +$12.6M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$7.57M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.93M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$16.1M | |
| 3 | -$11M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7.42M |
| 5 |
VM
VHCP Management
New York
|
-$5.58M |